NCT04620629 is a clinical trial in Antibiotic Side Effect, sponsored by H. Tolga Çelik.

Who is sponsoring NCT04620629?

NCT04620629 is sponsored by H. Tolga Çelik.

What condition does NCT04620629 study?

NCT04620629 studies Antibiotic Side Effect.

Is NCT04620629 still recruiting?

NCT04620629 is currently completed. Last updated 6 March 2023.

Last reviewed 2023-03-06 · How we verify

NCT04620629

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Probiotic Supplement on Urinary D-lactic Acid Level in Newborns

Completed Last updated 6 March 2023

What this trial tests

trial in Antibiotic Side Effect in 71 participants. Completed in 31 December 2020.

Timeline

1 February 2020

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	H. Tolga Çelik
Status	Completed
Study type	OBSERVATIONAL
Enrollment	71
Start date	1 February 2020
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Turkey (Türkiye)

Conditions studied

Antibiotic Side Effect — all drugs for Antibiotic Side Effect →

Sponsor

H. Tolga Çelik

Who can join

Adults 1 Day to 28 Days, any sex, with Antibiotic Side Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is thought that prophylactic enteral probiotics in newborns may play a role in the prevention of infection and NEC-related morbidity by preventing bacterial migration in the mucosa, reducing their number by competing with pathogenic bacteria, providing microbial balance, and increasing intestinal immunity. In our study, it was determined to detect normal D-lactic acid levels in urine in late premature (babies born after 34 weeks of gestation) and term babies, to show the negative effect of antibiotic treatment on the intestinal flora indirectly by measuring urinary D-lactic acid, and the probiotic support in babies using antibiotics was disrupted. The investigators aim to investigate hypothesis that it will have a corrective effect on the intestinal flora by comparing urinary D-lactic acid levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Antibiotic Side Effect

Currently open trials in the same condition.

NCT06018792 — Molecular Culture for the Diagnosis of Pediatric Sepsis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04620629 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by H. Tolga Çelik
Last refreshed: 6 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04620629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing